期刊
ADVANCED SYNTHESIS & CATALYSIS
卷 352, 期 18, 页码 3121-3125出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adsc.201000473
关键词
asymmetric catalysis; cyclic imines; enantioselectivity; hydrogenation; iridium
资金
- National Institutes of Health [GM58832]
- Merck Co., Inc.
A catalytic complex made from [Ir (COD)Cl](2) [di-mu-chloro-bis(1,5-cyclooctadiene)diridium(I)] precursor and (S,S)-f-Binaphane ((R,R)-1,1'-bis{bis{(R)-4,5-dihydro-3H-dinaphtho [1,2-c:2',1'-e]-phosphepino}ferrocene) ligand effectively catalyzed the enantioseselective hydrogenation of cyclic imines with high reactivity and good enantioselectivity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据